1,2,3-Triazole derivatives as antitubercular agents: synthesis, biological evaluation and molecular docking study

MedChemComm

Volumn 6, Issue 6, 2015, Pages 1104-1116

  Shaikh, Mubarak H ^a   Subhedar, Dnyaneshwar D ^a   Nawale, Laxman ^b   Sarkar, Dhiman ^b   Kalam Khan, Firoz A ^c   Sangshetti, Jaiprakash N ^c   Shingate, Bapurao B ^a  

^a DR BABASAHEB AMBEDKAR MARATHWADA UNIVERSITY   (India)

^b NATIONAL CHEMICAL LABORATORY   (India)

^c Y B CHAVAN COLLEGE OF PHARMACY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1 BENZYL 4 [PHENOXYMETHYL] 1H 1,2,3 TRIAZOLE; 1 [3 CHLOROBENZYL] 4 [[ 4 TOLYLOXY]METHYL] 1H 1,2,3 TRIAZOLE; 1 [3 CHLOROBENZYL] 4 [[4 CHLOROPHENOXY]METHYL] 1H 1,2,3 TRIAZOLE; 1 [3 NITROBENZYL] 4 [PHENOXYMETHYL] 1H 1,2,3 TRIAZOLE; 1 [3 NITROBENZYL] 4 [[4 CHLOROPHENOXY]METHYL] 1H 1,2,3 TRIAZOLE; 1 [4 BROMOBENZYL] 4 [PHENOXYMETHYL] 1H 1,2,3 TRIAZOLE; 1 [4 BROMOBENZYL] 4 [[ 4 TOLYLOXY]METHYL] 1H 1,2,3 TRIAZOLE; 1 [4 BROMOBENZYL] 4 [[4 CHLOROPHENOXY]METHYL] 1H 1,2,3 TRIAZOLE; 1 [4 CHLOROBENZYL] 4 [PHENOXYMETHYL] 1H 1,2,3 TRIAZOLE; 1 [4 CHLOROBENZYL] 4 [[ 4 TOLYLOXY]METHYL] 1H 1,2,3 TRIAZOLE; 1 [4 CHLOROBENZYL] 4 [[4 CHLOROPHENOXY]METHYL] 1H 1,2,3 TRIAZOLE; 1 [4 NITROBENZYL] 4 [PHENOXYMETHYL] 1H 1,2,3 TRIAZOLE; 1 [4 NITROBENZYL] 4 [[4 CHLOROPHENOXY]METHYL] 1H 1,2,3 TRIAZOLE; 1 [PROP 2 YNYLOXY]BENZENE; 1,1 DIPHENYL 2 PICRYLHYDRAZYL; 1,2,3 TRIAZOLE DERIVATIVE; 4 [[2,4,6 TRICHLOROPHENOXY]METHYL] 1 [3 NITROBENZYL] 1H 1,2,3 TRIAZOLE; 4 [[2,4,6 TRICHLOROPHENOXY]METHYL] 1 [4 CHLOROBENZYL] 1H 1,2,3 TRIAZOLE; 4 [[2,6 DIIODO 4 NITROPHENOXY]METHYL] 1 [4 BROMOBENZYL] 1H 1,2,3 TRIAZOLE; 4 [[2,6 DIIODO 4 NITROPHENOXY]METHYL] 1 [4 NITROBENZYL] 1H 1,2,3 TRIAZOLE; 4 [[3 NITROPHENOXY]METHYL] 1 [3 CHLOROBENZYL] 1H 1,2,3 TRIAZOLE; 4 [[3 NITROPHENOXY]METHYL] 1 [4 BROMOBENZYL] 1H 1,2,3 TRIAZOLE; 4 [[3 NITROPHENOXY]METHYL] 1 [4 CHLOROBENZYL] 1H 1,2,3 TRIAZOLE; 4 [[4 CHLORO 3 METHYLPHENOXY]METHYL] 1 [3 NITROBENZYL] 1H 1,2,3 TRIAZOLE; 4 [[4 CHLORO 3 METHYLPHENOXY]METHYL] 1 [4 CHLOROBENZYL] 1H 1,2,3 TRIAZOLE; ASCORBIC ACID; BUTYLCRESOL; ISONIAZID; RIFAMPICIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTITUBERCULAR ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CLICK CHEMISTRY; CYCLOADDITION; DRUG BIOAVAILABILITY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SCREENING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DOCKING; MYCOBACTERIUM TUBERCULOSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ROOM TEMPERATURE; STRUCTURE ACTIVITY RELATION; THIN LAYER CHROMATOGRAPHY; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84935830268     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c5md00057b     Document Type: Article

References (61)

1. Global tuberculosis control: WHO report, 2014
2. D. B. Young M. D. Perkins K. Duncan C. E. Barry J. Clin. Invest. 2008 118 1255
3. L. Christian V. Andrew M. C. Raviglione Curr. Opin. Pulm. Med. 2010 16 186
4. M. M. Sankar J. Singh S. C. A. Diana S. Singh Tuberculosis 2013 93 75
5. M. M. Singh Indian J. Tuberc. 2007 54 1
6. I. Wiid T. Seaman E. G. Hoal A. J. S. Benade P. D. V. Helden IUBMB Life 2004 56 101
7. J. E. Kinsella E. Frankel B. German J. Kanner J. Food Technol. J. Food Technol. 1993 47 85
8. R. Huisgen Angew. Chem. 1963 75 604
9. R. Huisgen J. Org. Chem. 1976 41 403
10. K. V. Gothelf K. A. Jorgensen Chem. Rev. 1998 98 863
11. V. V. Rostovtsev L. G. Green V. V. Fokin K. B. Sharpless Angew. Chem., Int. Ed. 2002 41 2596
12. C. W. Tornoe C. Christensen M. Meldal J. Org. Chem. 2002 67 3057
13. H. C. Kolb M. G. Finn K. B. Sharpless Angew. Chem., Int. Ed. 2001 40 2004
14. N. Boechat V. F. Ferreira S. B. Ferreira M. L. G. Ferreira F. C. da Silva M. M. Bastos M. S. Costa M. C. S. Lourenço A. C. Pinto A. U. Krettli A. C. Aguiar B. M. Teixeira N. V. da Silva P. R. C. Martins F. A. F. M. Bezerra A. L. S. Camilo G. P. da Silva C. C. P. Costa J. Med. Chem. 2011 54 5988
15. S. G. Agalave R. S. Maujan V. S. Pore Chem.-Asian J. 2011 6 2696
16. R. G. Lima-Neto N. N. M. Cavalcante R. M. Srivastava F. J. B. Mendonca A. G. Wanderley R. P. Neves J. V. dos Anjos Molecules 2012 17 5882
17. M. R. Senger L. C. A. Gomes S. B. Ferreira C. R. Kaiser V. F. Ferreira F. P. Silva Jr. ChemBioChem 2012 13 1584
18. P. Shanmugavelan S. Nagarajan M. Sathishkumar A. Ponnuswamy P. Yogeeswari D. Sriram Bioorg. Med. Chem. Lett. 2011 21 7273
19. K. I. Reddy K. Srihari J. Renuka K. S. Sree A. Chuppala V. U. Jeankumar J. P. Sridevi K. S. Babu P. Yogeeswari D. Sriram Bioorg. Med. Chem. 2014 22 6552
20. V. P. Krivopalov O. P. Shkurko Russ. Chem. Rev. 2005 74 339
21. R. Huisgen, in 1,3-dipolar cycloaddition chemistry, ed., A. Padwa, Wiley, New York, 1984, vol. 1, pp. 1-176
22. C. Menendez S. Gau C. Lherbet F. Rodriguez C. Inard M. R. Pasca M. Baltas Eur. J. Med. Chem. 2011 46 5524
23. C. Gill G. Jadhav M. Shaikh R. Kale A. Ghawalkar D. Nagargoje M. Shiradkar Bioorg. Med. Chem. Lett. 2008 18 6244
24. G. R. Labadie A. de la Iglesia H. R. Morbidoni Mol. Diversity 2011 15 1017
25. B. B. Shingate B. G. Hazra D. B. Salunke V. S. Pore F. Shirazi M. V. Deshpande Eur. J. Med. Chem. 2011 46 3681
26. A. H. Kategaonkar P. V. Shinde A. H. Kategaonkar S. K. Pasale B. B. Shingate M. S. Shingare Eur. J. Med. Chem. 2010 45 3142
27. A. H. Kategaonkar R. U. Pokalwar S. S. Sonar V. U. Gawali B. B. Shingate M. S. Shingare Eur. J. Med. Chem. 2010 45 1128
28. A. P. G. Nikalje A. N. Shaikh S. I. Shaikh F. A. K. Khan J. N. Sangshetti D. B. Shinde Bioorg. Med. Chem. Lett. 2014 24 5558
29. J. N. Sangshetti R. I. Shaikh F. A. K. Khan R. H. Patil S. D. Marathe W. N. Gade D. B. Shinde Bioorg. Med. Chem. Lett. 2014 24 1605
30. R. A. Limaye V. B. Kumbhar A. D. Natu M. V. Paradkar V. S. Honmore R. R. Chauhan S. P. Gample D. Sarkar Bioorg. Med. Chem. Lett. 2013 23 711
31. S. G. Alvarez M. T. Alvarez Synthesis 1997 4 413
32. U. Singh S. Akhtar A. Mishra D. Sarkar J. Microbiol. Methods 2011 84 202
33. A. Khan S. Sarkar D. Sarkar Int. J. Antimicrob. Agents 2008 32 40
34. S. Sarkar D. Sarkar J. Biomol. Screening 2012 17 966
35. M. Burits F. Bucar Phytother. Res. 2000 14 323
36. A. A. van de Loosdrecht R. H. Beelen G. J. Ossenkoppele M. G. Broekhoven M. M. Langenhuijsen J. Immunol. Methods 1994 174 311
37. M. C. Alley D. A. Scudiere A. Monks M. L. Hursey M. J. Czerwinski D. L. Fine B. J. Abbott J. G. Mayo R. H. Shoemaker M. R. Boyd Cancer Res. 1988 48 589
38. T. Mosmann J. Immunol. Methods 1983 65 55
39. G. Ciapetti E. Cenni L. Pratelli A. Pizzoferrato Biomaterials 1993 14 359
40. C. M. Doyen Y. M. Moshkin G. E. Chalkley K. Bezstarosti J. A. Demmers C. Rathke R. Renkawitz-Pohl C. P. Verrijzer Cell Rep. 2003 4 59
41. R. C. Hartkoorn B. Chandler A. Owen S. A. Ward S. B. Squire D. J. Back S. H. Khoo Tuberculosis 2007 87 248
42. I. Orme J. Secrist S. Anathan C. Kwong J. Maddry R. Reynolds Antimicrob. Agents Chemother. 2001 7 1943
43. X. Luo D. Pires J. A. Ainsa B. Gracia N. Duarte S. Mulhovo E. Anes M. J. U. Ferreira J. Ethnopharmacol. 2013 146 417
44. L. G. Wayne L. G. Hayes Infect. Immun. 1996 64 2062
45. M. Fauzia S. Syed M. S. Zaman P. K. Nitin S. R. Vikrant M. Chaitanya M. Naveen A. K. Inshad M. S. Alam Eur. J. Med. Chem. 2014 76 274
46. S. A. Stanley S. S. Grant T. Kawate N. Iwase M. Shimizu C. Wivagg M. Silvis E. Kazyanskaya J. Aquadro A. Golas M. Fitzgerald H. Dai L. Zhang D. T. Hung ACS Chem. Biol. 2012 7 1377
47. G. Riccardi M. R. Pasca L. R. Chiarelli G. Manina A. Mattevi C. Binda Appl. Microbiol. Biotechnol. 2013 87 8841
48. S. M. Batt T. Jabeen V. Bhowruth L. Quill P. A. Lund L. Eggeling L. J. Alderwick K. Futterer G. S. Besra Proc. Natl. Acad. Sci. U. S. A. 2012 109 11354
49. VLife Molecular Design Suite 4.3, VLife Sciences Technologies Pvt. Ltd.; www.Vlifesciences.com
50. C. A. Lipinski L. Lombardo B. W. Dominy P. J. Feeney Adv. Drug Delivery Rev. 2001 46 3
51. Molinspiration Chemoinformatics Brastislava, Slovak Republic, available from: http://www.molinspiration.com/cgi-bin/properties, 2014
52. Y. Zhao M. H. Abraham J. Lee A. Hersey N. C. Luscombe G. Beck B. Sherborne I. Cooper Pharm. Res. 2002 19 1446
53. Drug-likeness and molecular property prediction, available from: http://www.molsoft.com/mprop/
54. P. Ertl B. Rohde P. Selzer J. Med. Chem. 2000 43 3714
55. G. Ciapetti E. Cenni L. Pratelli A. Pizzoferrato Biomaterials 1993 14 359
56. T. Mosmann J. Immunol. Methods 1983 65 55
57. J. P. Dzoyem S. K. Guru C. A. Pieme V. Kuete A. Sharma I. A. Khan A. K. Saxena R. A. Vishwakarma BMC Complementary Altern. Med. 2013 13 78
58. M. Protopopova C. Hanrahan B. Nikonenko R. Samala P. Chen J. Gearhart L. Einck C. A. Nacy J. Antimicrob. Chemother. 2005 56 968
59. M. Poggi R. Barroso A. J. Costa-Filho H. B. de Barros F. Pavan C. Q. Leite D. Gambino M. H. Torre J. Mex. Chem. Soc. 2013 57 198
60. L. L. Gundersen J. N. Meyer B. Spilsberg J. Med. Chem. 2002 45 1383
61. K. K. Sivakumar A. Rajasekaran Int. J. Drug Des. Discovery 2013 1065